CN104603622B - 用于提高辅助受精中的着床成功率的方法 - Google Patents

用于提高辅助受精中的着床成功率的方法 Download PDF

Info

Publication number
CN104603622B
CN104603622B CN201380046019.3A CN201380046019A CN104603622B CN 104603622 B CN104603622 B CN 104603622B CN 201380046019 A CN201380046019 A CN 201380046019A CN 104603622 B CN104603622 B CN 104603622B
Authority
CN
China
Prior art keywords
state
unk
cells
endometrial
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380046019.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN104603622A (zh
Inventor
N·赖德
M·佩蒂特巴拉特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MATRICELAB INNOVE
Original Assignee
MATRICELAB INNOVE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MATRICELAB INNOVE filed Critical MATRICELAB INNOVE
Publication of CN104603622A publication Critical patent/CN104603622A/zh
Application granted granted Critical
Publication of CN104603622B publication Critical patent/CN104603622B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1089Design, preparation, screening or analysis of libraries using computer algorithms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/367Infertility, e.g. sperm disorder, ovulatory dysfunction
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
CN201380046019.3A 2012-07-20 2013-07-19 用于提高辅助受精中的着床成功率的方法 Active CN104603622B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12177377.4A EP2687851A1 (en) 2012-07-20 2012-07-20 Method for increasing implantation success in assisted fertilization
EP12177377.4 2012-07-20
PCT/EP2013/065355 WO2014013079A1 (en) 2012-07-20 2013-07-19 Method for increasing implantation success in assisted fertilization

Publications (2)

Publication Number Publication Date
CN104603622A CN104603622A (zh) 2015-05-06
CN104603622B true CN104603622B (zh) 2017-08-01

Family

ID=48874275

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380046019.3A Active CN104603622B (zh) 2012-07-20 2013-07-19 用于提高辅助受精中的着床成功率的方法

Country Status (16)

Country Link
US (1) US10450561B2 (https=)
EP (2) EP2687851A1 (https=)
JP (1) JP6411340B2 (https=)
CN (1) CN104603622B (https=)
AU (1) AU2013291941B2 (https=)
BR (1) BR112015001157B1 (https=)
CA (1) CA2879467C (https=)
DK (1) DK2877856T3 (https=)
ES (1) ES2740548T3 (https=)
HU (1) HUE046835T2 (https=)
IL (1) IL236824B (https=)
PL (1) PL2877856T3 (https=)
PT (1) PT2877856T (https=)
RU (1) RU2730873C2 (https=)
SI (1) SI2877856T1 (https=)
WO (1) WO2014013079A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114927178A (zh) * 2015-06-12 2022-08-19 格尼亚Ip控股私人有限公司 患者和生物样本识别和追踪的方法和系统
WO2017054038A1 (en) 2015-09-30 2017-04-06 Prince Henry's Institute Of Medical Research Trading As The Hudson Institute Of Medical Research A method of treatment and prognosis
CN105784983B (zh) * 2016-01-13 2017-10-31 深圳中山生殖与遗传研究所 一种评估子宫内膜容受性的试剂盒及其使用方法
CZ2017255A3 (cs) 2017-05-04 2018-11-14 Zentiva, K.S. Filmem potažené tablety Deferasiroxu
EP3914915A1 (en) * 2019-01-25 2021-12-01 Fertility Lab Sciences, LLC Uterine endometrial fluid for prediction of success in fertility treatment
CN110042156B (zh) 2019-04-22 2021-12-28 苏州亿康医学检验有限公司 一种判断子宫内膜容受性的方法及其应用
CN110148446B (zh) * 2019-05-21 2023-06-16 重庆市柏玮熠科技有限公司 Ivf样本核对系统
CN114599798A (zh) * 2019-06-25 2022-06-07 哈德逊医学研究所 预测子宫内膜容受性的方法
GB201911947D0 (en) * 2019-08-20 2019-10-02 Univ Warwick Miscarriage biomarkers
RU2732432C1 (ru) * 2020-03-31 2020-09-16 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ оценки эндометриальной дисфункции у женщин с первичным эндометриоз-ассоциированным бесплодием
CN111624354A (zh) * 2020-06-05 2020-09-04 佛山迪安医学检验实验室有限公司 一种诊断试剂盒及诊断方法
CN111772682B (zh) * 2020-07-10 2021-08-13 北京大学第三医院(北京大学第三临床医学院) 预测受试者出现卵巢储备新变化年限的系统和方法
CN111778326B (zh) * 2020-07-14 2021-10-22 和卓生物科技(上海)有限公司 用于子宫内膜容受性评估的基因标志物组合及其应用
RU2748191C1 (ru) * 2021-01-21 2021-05-20 Мекан Рахимбердыевич Оразов Способ определения степени выраженности хронического эндометрита у женщин с маточным фактором бесплодия после неудачного экстракорпорального оплодотворения в анамнезе (варианты)
EP4407626A1 (fr) * 2023-01-30 2024-07-31 Sofia Procédé de génération de recommandations diagnostiques et/ou thérapeutiques en fertilité

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1004154B (el) * 2001-05-21 2003-02-20 Μεθοδος διερευνησης του ενδομητριου με εξετασεις που εφαρμοζονται επι του ιστου αποπεπτωκοτος ενδομητριου (ιστου περιοδου)
US7175990B2 (en) 2002-02-26 2007-02-13 The Regents Of The University Of California Method of determining endometrial receptivity
US20100150862A1 (en) * 2006-12-07 2010-06-17 Schering Corporation Methods of modulating maternal-fetal tolerance
CN105224827B (zh) * 2008-07-01 2019-12-24 小利兰·斯坦福大学托管委员会 用于发展ivf治疗协议的分析数据的计算机系统和存储介质
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
WO2011000805A1 (en) * 2009-06-29 2011-01-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarkers of oocyte competency and method of use
EP2348318A1 (en) 2010-01-21 2011-07-27 Equipo Ivi Investigación, S.L. Diagnostic method for endometrial receptivity
JP6219164B2 (ja) * 2010-05-27 2017-10-25 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 患者の子宮内膜の受容性を評価するための方法
BR112013000879A2 (pt) * 2010-07-13 2016-05-17 Univfy Inc método de avaliação do risco de nascimento múltiplos em travamentos para infertilidade
RU2444315C1 (ru) * 2010-09-03 2012-03-10 Михаил Григорьевич Шнейдерман Способ повышения возможности удачной имплантации эмбриона к эндометрию полости матки

Also Published As

Publication number Publication date
PL2877856T3 (pl) 2019-11-29
BR112015001157B1 (pt) 2022-03-29
CA2879467C (en) 2021-11-09
EP2877856A1 (en) 2015-06-03
JP2015531057A (ja) 2015-10-29
ES2740548T3 (es) 2020-02-05
SI2877856T1 (sl) 2019-11-29
US10450561B2 (en) 2019-10-22
IL236824B (en) 2018-06-28
DK2877856T3 (da) 2019-08-12
WO2014013079A1 (en) 2014-01-23
EP2877856B1 (en) 2019-07-10
HK1210835A1 (en) 2016-05-06
AU2013291941A1 (en) 2015-02-12
RU2730873C2 (ru) 2020-08-26
RU2016106004A (ru) 2017-12-08
BR112015001157A2 (https=) 2017-08-15
US20150184152A1 (en) 2015-07-02
CA2879467A1 (en) 2014-01-23
HUE046835T2 (hu) 2020-03-30
AU2013291941B2 (en) 2019-05-02
PT2877856T (pt) 2019-08-21
EP2687851A1 (en) 2014-01-22
CN104603622A (zh) 2015-05-06
JP6411340B2 (ja) 2018-10-24

Similar Documents

Publication Publication Date Title
CN104603622B (zh) 用于提高辅助受精中的着床成功率的方法
Regan et al. Recurrent miscarriagegreen‐top guideline no. 17.
Rezaeiye et al. Impact of various parameters as predictors of the success rate of in vitro fertilization
Tuckerman et al. Uterine natural killer cells in peri-implantation endometrium from women with repeated implantation failure after IVF
Franasiak et al. Vitamin D levels do not affect IVF outcomes following the transfer of euploid blastocysts
Lédée-Bataille et al. Role of the endometrial tripod interleukin-18,-15, and-12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization–embryo transfer failure
Cederholm et al. Maternal complications following amniocentesis and chorionic villus sampling for prenatal karyotyping
Badawy et al. Prediction and diagnosis of poor ovarian response: the dilemma
Cheloufi et al. The endometrial immune profiling may positively affect the management of recurrent pregnancy loss
Papanikolaou et al. Identification of the high-risk patient for ovarian hyperstimulation syndrome
Ganer Herman et al. Does embryo quality at transfer affect obstetric outcomes and placental findings?
Shim et al. Maternal antimullerian hormone as a predictor of fetal aneuploidy occurring in an early pregnancy loss
Fadini et al. Anti-mullerian hormone as a predictive marker for the selection of women for oocyte in vitro maturation treatment
Dumancic et al. Histopathologic characteristics of term placentas in singleton pregnancies in women with endometriosis-related infertility after ART treatment: case-control study
Wong et al. Do uterine natural killer cell numbers in peri-implantation endometrium predict hypertensive disorder in pregnancy in women with a history of reproductive failure?
Løssl et al. Predictive value of plasma human chorionic gonadotropin measured 14 days after Day‐2 single embryo transfer
Simpson et al. Peri‐implantation cytokine profile differs between singleton and twin IVF pregnancies
George et al. The role of reproductive immunology in recurrent pregnancy loss and repeated implantation failure
Leubner et al. Immediate postplacental intrauterine device placement: retrospective cohort study of expulsion and associated risk factors
HK1210835B (en) Method for increasing implantation success in assisted fertilization
Ledee et al. Using endometrial immune profiling in young IVF patients: implantation rates improved for morphologically sub-optimal embryos
No Recurrent Miscarriage
Kaser et al. When is treatment with clomiphene or gonadotropin IUI futile? Results of FASTT and FORT-T, two prospective randomized controlled trials
Cheloufi et al. Lede e N (2021) The Endometrial Immune Profiling May Positively Affect the Management of Recurrent Pregnancy Loss
Hofmann et al. Obstetric implications for and identification of women with a normal clomiphene citrate challenge test result who have a poor response to gonadotropins

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant